Quest Diagnostics, the world’s leading provider of diagnostic testing, information, and services, offers a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed to be the most comprehensive panel clinically...
Chopra in the April 2004 issue describing the measurement of 3.3袌-diiodothyronine sulfate (T2S) in thyroidal and nonthyroidal disease, pregnancy, and fetal/neonatal life.1 In the article, the author describes development of a sensitive and specific radioimmunoassay for T2S, and reports a 5-...
We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some...
A seven (or eight) gene mutation panel which includes BRAF, KRAS, HRAS, NRAS, and RET/PTC1, RET/PTC3, PAX8/PPARγ (and TRK) rearrangements is the best characterized molecular panel. The presence of any mutation has high specificity and high PPV for malignancy, as demonstrated in three ...
Lastly, cytotoxicity of P4-10bbz CAR T cells was tested against a panel of primary human cells, including human keratinocytes, and showed specific lysis of only the control TT cell targets (Figure S18). Although the target antigen in mouse KCs remains unknown, the aggregate data suggest that...